Lincoln Pharmaceuticals Ltd Share Price
(LINCOLN)
₹552.2▲0.13%
as on 04:01PM, 01 Apr 2025
Lincoln Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹549.2Day's Price Range₹563.5552 Week's Low
52 Week's High
₹49952-Week Price Range₹979.5
| Returns % | |
| 1 Month Return | + 1.85 % |
| 3 Month Return | -35.65 % |
| 1 Year Return | -7.77 % |
| Market Stats | |
| Previous Close | ₹551.50 |
| Open | ₹554.55 |
| Volume | 35.83K |
| Upper Circuit | ₹661.80 |
| Lower Circuit | ₹441.20 |
| Market Cap | ₹1,104.64Cr |
Lincoln Pharmaceuticals Ltd Fundamentals
P/E Ratio
12.36
PEG Ratio
11.77
Market Cap
₹1,104.64 Cr
P/B Ratio
1.98
EPS
46.58
Dividend Yield
0.31
Sector
Pharmaceuticals
ROE
17.04
Mutual Fund Holdings of Lincoln Pharmaceuticals Ltd
Key events for Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Stock Surges 7.88% on January 1, 2025 - 01 Jan, 2025
On January 1, 2025, Lincoln Pharmaceuticals stock rose by 7.88%, outperforming its sector. The stock reached an intraday high of Rs 857.6 and showed a monthly increase of 35.78%. Despite high volatility, it remains above key moving averages, with a Hold rating from MarketsMOJO.Lincoln Pharmaceuticals Surges 7.83% on December 30 - 30 Dec, 2024
On December 30, 2024, Lincoln Pharmaceuticals gained 7.83%, outperforming its sector. The stock reached an intraday high of Rs 794.95 and has risen 32.86% over the past month, while the Sensex declined by 1.46%. It is rated as Hold by MarketsMOJO, indicating a stable outlook.Lincoln Pharmaceuticals Hits Upper Circuit with Strong Performance - 03 Dec, 2024
On December 3, 2024, Lincoln Pharmaceuticals' stock surged 20% to Rs 763.20, driven by high trading volumes and increased FII stake. The company reported consistent profit growth and aims for Rs 750 crore revenue by FY26, bolstered by strong liquidity and zero debt.
Insights on Lincoln Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 45.03% to 45.06% in Dec 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 61.9% return, outperforming this stock by 69.6%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.7% return, outperforming this stock by 61.5%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 49.78% of holdings in Dec 2024 quarter
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 171.19 Cr → 155.52 Cr (in ₹), with an average decrease of 9.2% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 5.19% to 5.16% in Dec 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 months, LINCOLN stock has moved down by -35.7%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 26.33 Cr → 20.77 Cr (in ₹), with an average decrease of 21.1% per quarter
Lincoln Pharmaceuticals Ltd Financials
Lincoln Pharmaceuticals Ltd Index Inclusions
Lincoln Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 49.78% | 0.00 | |
| Foreign Institutions | 5.16% | ||
| Mutual Funds | 0% | 38.46 | |
| Retail Investors | 45.06% | 0.07 | |
| Others | 0% |
Lincoln Pharmaceuticals Ltd Key Indicators
Lincoln Pharmaceuticals Ltd Valuation
Lincoln Pharmaceuticals Ltd in the last 5 years
Lowest (3.58x)
March 23, 2020
Today (12.36x)
March 28, 2025
Industry (53.18x)
March 28, 2025
Highest (19.77x)
December 9, 2024
Lincoln Pharmaceuticals Ltd Earnings and Dividends
Lincoln Pharmaceuticals Ltd Earnings Results
Lincoln Pharmaceuticals Ltd’s net profit fell -25.93% since last year same period to ₹20.77Cr in the Q3 2024-2025. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated -21.12% fall in its net profits since last 3-months.
Read More about Earnings ResultsLincoln Pharmaceuticals Ltd Dividends May,2024
In the quarter ending March 2024, Lincoln Pharmaceuticals Ltd has declared dividend of ₹1.80 - translating a dividend yield of 0.60%.
Read More about Dividends
Lincoln Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Lincoln Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Lincoln Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹1,104.64 Cr | 69.42% | 0.50 | ₹93 Cr | ₹580 Cr | |
| NA | ₹747.62 Cr | 34.1% | 0.51 | NA | NA | |
| NA | ₹2,116.87 Cr | 16.93% | 0.79 | NA | NA | |
| NA | ₹190.52 Cr | 110.43% | 0.66 | ₹5 Cr | ₹155 Cr | |
| NA | ₹65.86 Cr | 136.6% | 0.80 | NA | NA |
About Lincoln Pharmaceuticals Ltd
Revenue: ₹146.55Cr as on December 2024 (Q4 24)
Net Profit: ₹20.77Cr as on December 2024 (Q4 24)
Listing date: 17 Dec, 2015
Chairperson Name: Kishorbhai M Shah
| Organisation | Lincoln Pharmaceuticals Ltd |
| Headquarters | Ahmedabad |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Lincoln Pharmaceuticals Ltd
What is Lincoln Pharmaceuticals Ltd price today?
Lincoln Pharmaceuticals Ltd share price today stands at ₹552.2, Open: ₹554.55, Previous Close: ₹551.5, High: ₹563.55, Low: ₹549.2, 52 Week High: ₹979.5, 52 Week Low: ₹499.
How to Buy Lincoln Pharmaceuticals Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Lincoln Pharmaceuticals Ltd shares
What are today's traded volumes of Lincoln Pharmaceuticals Ltd?
Today's traded volume of Lincoln Pharmaceuticals Ltd(LINCOLN) is 35.83K.
What is today's market capitalisation of Lincoln Pharmaceuticals Ltd?
Today's market capitalisation of Lincoln Pharmaceuticals Ltd(LINCOLN) is ₹1104.64Cr.
What is the 52 Week High and Low Range of Lincoln Pharmaceuticals Ltd?
How much percentage Lincoln Pharmaceuticals Ltd is down from its 52 Week High?
Lincoln Pharmaceuticals Ltd (LINCOLN) share price is ₹552.2. It is down -43.62% from its 52 Week High price of ₹979.5
How much percentage Lincoln Pharmaceuticals Ltd is up from its 52 Week low?
Lincoln Pharmaceuticals Ltd (LINCOLN) share price is ₹552.2. It is up 10.66% from its 52 Week Low price of ₹499